I believe in providing care that is personalized and state of the art, while also maintaining the crucial personal relationship with my patients.
There are many things I enjoy about practicing medicine at Ohio State. I appreciate the element of continued learning that comes from being at an academic hospital on a great campus. It provides valuable opportunities to collaborate across specialties and disciplines. This team approach allows us to offer better patient care.
In my free time, I enjoy relaxing with family and watching the Columbus Clippers.
- Research interests in PTEN hamartoma tumor syndrome (Cowden syndrome) and other inherited colon cancer syndromes
- Co-authored Cowden syndrome section for UpToDate, the premier medical reference
- Received Robert J. Fass Award for Outstanding Clinical Fellow
- Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2016
Medical College of Ohio
7/1/2009 - 7/1/2011
Specialties and conditions I treat
- Colonic Polyps
- Digestive System Diseases
- Esophageal Achalasia
- Esophageal Motility Disorders
- Rectal Cancers
- Celiac Disease
- Barrett Esophagus
Locations where I practice
Stoneridge Medical Services
More about my work
Ohio State University Wexner Medical Ctr
7/1/2011 - 6/30/2014
American Board of Internal Medicine
American Board of Internal Medicine (Subspecialty: Gastroenterology)
Gastroenterology, Hepatology and Nutrition
News about me
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/25/2016, Dr. Stanich has reported no financial relationships with medical device, research and/or drug companies.